FDA approves Celgenes R2 for two types of indolent lymphoma
Celgene has announced that the US FDA has approved Revlimid (lenalidomide) in combination with rituximab (R2) for patients with previously treated follicular lymphoma (FL)...
ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has...
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
For an extended time, IBT has consulted with the US FDA on how the company’s planned Phase III study should be designed.
IBT announced the...
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis
Allergan plc announced the expansion of the PLEDGE program with a fifth study now evaluating relamorelin, an investigational, ghrelin agonist being studied for the...
Circuit Clinical adds Big Data – AI capabilities in Precision Medicine partnership with CUBRC
Circuit Clinical, one of the nation's largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, announced a...
Impulse Dynamics announces successful implantation of first patient since FDA approval of Optimizer Smart System
Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering CCM therapy, announced that the first patient to receive the Optimizer Smart System...
AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...